Monday - July 27, 2026
UB spinout POP Biotechnologies receives up to $9.7 million for rapid-response vaccine platform
June 11, 2026
BUFFALO, New York, June 11 -- The University at Buffalo (State University of New York) posted the following news release:

* * *

UB spinout POP Biotechnologies receives up to $9.7 million for rapid-response vaccine platform

*

Jonathan Lovell, SUNY Empire Innovation Professor in the Department of Biomedical Engineering, and co-founder and CEO of POP Biotechnologies. Credit: Douglas Levere, University at Buffalo.

Funding will help Bu . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products